Jefferies has upgraded Cardinal Health (CAH) to buy from hold, citing management's emerging EPS track record. Read more here.

Dublin, Ohio-based Cardinal Health, Inc. (CAH) manufactures and distributes pharmaceuticals, medical & laboratory products, ...

The board of Cardinal Health, Inc. ( NYSE:CAH ) has announced that it will pay a dividend on the 15th of April, ...

Jefferies analyst Brian Tanquilut upgraded Cardinal Health (CAH) to Buy from Hold with a price target of $150, up from $140. The firm thinks ...

Key Insights Given the large stake in the stock by institutions, Cardinal Health's stock price might be vulnerable ...

Mizuho Securities analyst Steven Valiquette has reiterated their bullish stance on CAH stock, giving a Buy rating yesterday.Invest with ...

One company to watch right now is Cardinal Health (CAH). CAH is currently sporting a Zacks Rank of #2 (Buy), as well as a Value grade of A. The stock holds a P/E ratio of 14.87, while its industry ...

A local school district will not move forward with the purchase of a Cardinal Health building it planned to utilize for ...

Jefferies Financial Group upgraded shares of Cardinal Health (NYSE:CAH – Free Report) from a hold rating to a buy rating in a report released on Wednesday morning, Marketbeat reports. The brokerage ...

Cardinal Health warned Thursday that if President Donald Trump follows through with threatened tariffs next month, higher ...